110
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Sevoflurane reduces ischemic brain injury in rats with diet and streptozotocin-induced diabetes

, , , &
Pages 448-454 | Received 10 Sep 2018, Accepted 22 Jan 2019, Published online: 30 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

LiGuo Song, LuYan Mu & HongLiang Wang. (2022) MicroRNA-489-3p aggravates neuronal apoptosis and oxidative stress after cerebral ischemia-reperfusion injury. Bioengineered 13:6, pages 14047-14056.
Read now

Articles from other publishers (3)

Weijian Fan, Jianjie Rong, Weihao Shi, Wei Liu, Jie Wang, Jinyun Tan, Bo Yu & Jindong Tong. (2023) GATA6 Inhibits Neuronal Autophagy and Ferroptosis in Cerebral ischemia-reperfusion Injury Through a miR-193b/ATG7 axis-dependent Mechanism. Neurochemical Research 48:8, pages 2552-2567.
Crossref
Zhiguo Wu, Jian Tan, Lichang Lin, Wenting Zhang & Wanqiu Yuan. (2022) Sevoflurane up-regulates miR-7a to protect against ischemic brain injury in rats by down-regulating ATG7 and reducing neuronal autophagy. Brain Research Bulletin 188, pages 214-222.
Crossref
Bin Zhao, Peng Wang, Jing Yu & Yizhi Zhang. (2021) RETRACTED: MicroRNA-376b-5p targets SOX7 to alleviate ischemic brain injury in a mouse model through activating Wnt/β-catenin signaling pathway. Life Sciences 270, pages 119072.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.